TC Biopharm
TC Biopharm is a Scotland-based clinical-stage biotechnology company that develops and commercializes CAR-T cell therapies for the treatment of cancer.
Business Model:
Revenue: $2.7M
Employees: 51-200
Industries / Tags:
Detailed TC Biopharm Information
Geographic Data
Address: Maxim 1, 2 Parklands Way,
City: Holytown
State: scotland
Zip: ML1 4WR
Country: GB
Financial Info
Stage:
post ipo equity
Raised Last:
$4M
Raised Total:$40M
Social
Metrics
1,913,062Website Global Rank
11,290Website Monthly Traffic
Twitter Followers
Description
TC Biopharm is a Scotland-based clinical-stage biotechnology company that develops and commercializes CAR-T cell therapies for the treatment of cancer.
Contact Phone:
Contact Email:
TC Biopharm went public on 2/11/2022 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/11/2022
IPO Valuation:
$119M
Ticker Symbol:
TCBP
IPO Price:
$4.25/share
Amount Raised:
$18M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
